The best NAD⁺ supplement: an evidence-first buyer's guide

Search for the “best NAD⁺ supplement” and you will be sold patches, nasal sprays, sublingual tabs and capsules stamped simply “NAD⁺.” Most of that is the wrong thing to buy. The honest answer is narrower and better evidenced: the supplements with actual human data behind them are the NAD⁺ precursors — nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) — because controlled trials show they raise the NAD⁺ markers in your blood. This is a buyer's guide built on that distinction, and on criteria you can verify rather than star ratings we made up.

What “best” actually means when you buy an NAD⁺ supplement

NAD⁺ (nicotinamide adenine dinucleotide) is a coenzyme every cell uses, and its levels fall with age — which is why a whole product category has grown up around “restoring” it. The problem is that the intact NAD⁺ molecule is large and unstable, and there is little good human evidence that swallowing it, sticking it on your skin, or spraying it up your nose meaningfully raises what reaches your cells. So “best” here is not about which brand feels most premium. It is about which product buys you the thing that has been measured in people: a rise in blood NAD⁺. For the full mechanism and the trial record, see our deep dive on the evidence for NR and NMN as NAD⁺ precursors.

Buy a precursor: NR or NMN

Nicotinamide riboside is the most thoroughly characterized. A crossover study showed a single oral dose is orally bioavailable in humans and raises the blood NAD⁺ metabolome.^[1] A longer randomized, double-blind, placebo-controlled trial of NR chloride (the ingredient marketed as Niagen) in healthy overweight adults found it raised whole-blood NAD⁺ in a dose-dependent, sustained fashion and was well tolerated across doses up to 1,000 mg/day.^[2] A separate placebo-controlled trial in men reported it was safe over six weeks.^[3]

NMN sits one biochemical step closer to NAD⁺ and now has its own controlled human data. A randomized trial in prediabetic women used 250 mg/day and reported improved muscle insulin sensitivity,^[4]and a double-blind, placebo-controlled study in older adults found NMN raised blood NAD⁺ levels.^[5]A longer randomized trial likewise showed NMN supplementation changed NAD⁺ metabolism over time.^[6]The common thread is the only claim the data actually support well: precursors raise NAD⁺ markers.

You can walk through the same trade-offs interactively with our NAD⁺ format comparator.

The six criteria that separate a good buy from a bad one

Because we cannot honestly rank named brands on invented test results, rank them yourself on what is verifiable:

1. Proven ingredient. Choose NR or NMN — forms with human pharmacokinetic data — over anything labeled only “NAD⁺.”^[1]
2. A clinically studied dose. NR trials cluster around 300–1,000 mg/day;^[2] NMN human trials have run from about 250 mg/day upward.^[4] Match the label to those amounts.
3. Third-party testing and a certificate of analysis (CoA). Independent lab work matters most for NMN, where measured purity between products varies widely. Insist on a batch CoA showing identity and purity.
4. GMP manufacturing and label transparency. Made in a cGMP facility, with the precursor dose stated per serving — not hidden inside a proprietary “blend.”
5. Regulatory status you understand. See the note below on NMN; it affects where and how a product can be sold.
6. Price per studied daily dose. Normalize cost to the dose that was actually trialed, not per capsule or per gram of a blend. That number is what our breakdown of NMN cost and the guide to NAD⁺ injection costs exist to make comparable.

The honest ceiling: markers are not outcomes

Here is the line the marketing blurs. Raising blood NAD⁺ is proven; making you live longer or reversing a disease is not. The human trials measure biomarkers and short-term endpoints — NAD⁺ levels, insulin sensitivity, tolerability — not lifespan, and not hard clinical outcomes.^[4][5] A precursor supplement is a reasonable, evidence-backed way to raise a biomarker that declines with age. It is not a proven longevity therapy, and anything sold as one is overselling the data. If you are weighing precursors against clinic-based routes, our overviews of NAD⁺ IV therapy lay out how thin that evidence is too.

Bottom line

The “best NAD⁺ supplement” is not a NAD⁺ supplement at all — it is a precursor. Buy NR or NMN at a clinically studied dose, from a GMP maker that will show you a certificate of analysis, at the lowest price per studied daily dose, and understand the NMN regulatory situation before you commit. Do that and you are buying the one effect the science actually supports: a measurable rise in NAD⁺. Just keep the claim honest — you are topping up a biomarker, not buying more years.